Eliseu Labigalini Jr, Lucio Ribeiro Rodrigues, Dartiu Xavier Da Silveira
01 October 1999
This study ensued from clinical observations based on spontaneous accounts by crack abusers undergoing their first psychiatric assessment, where they reported using cannabis in an attempt to ease their own withdrawal symptoms.
In the city of São Paulo, the culture of crack use has undergone considerable changes over these 11 years since it was first described. The sociodemographic profile of the users is practically the same and most use is still compulsive, with significant physical, moral and social impairment among them. Sole use of crack has overwhelmingly been replaced by associations between crack and other drugs, thus characterizing users in the city of São Paulo as multiple drug users.
An ethnographic study of women and drug use in inner city neighborhoods in Kingston, Jamaica, revealed that cannabis is commonly used in conjunction with crack cocaine to minimize the undesirable effects of crack pipe smoking, specifically paranoia and weight loss.
BBC Mundo reports that Bogotá is planning a system of "controlled consumption centers," where addicts could be weaned off more hard-core drugs, such as heroin or crack (bazuco), and slowly introduced to pot. Because of its continued prevalence, as well as its toxicity, bazuco will be one of the drugs targeted by Mayor Gustavo Petro's planned treatment centers. The treatment centers are part of a larger movement in Colombia to classify drug addiction as an issue of public health rather than crime.
Marcus Day of the Caribbean Drug and Alcohol Research Institute believes the time has come for regional governments to legalise marijuana to counteract the spread of HIV. "We encourage the crack smokers that we work with to substitute their crack for cannabis and to smoke cannabis instead. Even though it's probably not the best thing, it's much better than crack smoking."
Marijuana has long been accused of being a gateway to deadlier vices. But could cannabis be a swinging door that might also lead people away from hard drugs? That’s what this capital city is trying to find out. In coming weeks, Bogotá is embarking on a controversial public health project where it will begin supplying marijuana to 300 addicts of bazuco — a cheap cocaine derivative that generates crack-like highs and is as addictive as heroin.
Research being conducted by a former Victoria city councillor is poking holes in marijuana’s reputation as a gateway drug. According to an academic paper authored by Philippe Lucas, marijuana may be an effective substitute for prescription drugs or alcohol, similar to the way methadone is used to treat heroin addicts. “The evidence suggests that cannabis is a potential exit drug for addiction,” Lucas said.
The mayor of Bogota has recently proposed a pilot scheme with crack cocaine addicts to explore the substitution of crack made of cocaine base paste (or bazuco as it is called in Colombia) by marijuana. The substitution treatment plan will include 15 problematic users from the marginalized Bronx area who are already receiving health assistance of the CAMAD operating in that sector of the city. The treatment will last approximately eight months, after which the results will be evaluated.
Philippe Lucas, Amanda Reiman, Mitch Earleywine, Stephanie K. McGowan, Megan Oleson, Michael P. Coward, Brian Thomas
19 November 2012
This article examines the subjective impact of medical cannabis on the use of both licit and illicit substances via self-report from 404 medical cannabis patients recruited from four dispensaries in British Columbia, Canada. The aim of this study is to examine a phenomenon called substitution effect, in which the use of one product or substance is influenced by the use or availability of another.
There is a growing body of evidence to support the use of medical cannabis as an adjunct to or substitute for prescription opiates in the treatment of chronic pain. When used in conjunction with opiates, cannabinoids lead to a greater cumulative relief of pain, resulting in a reduction in the use of opiates (and associated side-effects) by patients in a clinical setting. Additionally, cannabinoids can prevent the development of tolerance to and withdrawal from opiates, and can even rekindle opiate analgesia after a prior dosage has become ineffective.